Replies to post #115669 on PCT Ltd (PCTL)

[namtae]

Fluid sales arent likely to drop off, more likely to increase as disinfecting will remain priority with hospitals and general use, regardless of CV.

That said, CV isnt going away soon and PCT fluids are not and will not be PCTs core business anyway

Fortunately, leasing Annihilyzers under multiple year contracts basically assures ongoing, growing recurring revenue base.

Expansion into other revenue streams very possible.

Again, a sharp exec would have PCT rocking like you cant believe. The opportunity is massive

PCT may still become a very successful company in spite of its CEO trainee, but the odds get longer the longer hes CEO

[falon]

PCTL business plan was to sell the Annihilyer to every hospital in the world. I'm exaggerating of course. Their focus and emphasis has always been the Annihilyzer. They have one in 22 percent of the 62 acute care facilities in NY City and that number is going up.

The Annihilyzer is no joke of a system and there is only one system on the market that is similar and we have a court case with that company.

The podcast talked about the PCTL need to accelerate expansion because of demand.

The fluid sales will eventually level out. The question to be settle is where will that level will be. HOCI may become a staple for many businesses moving forward.